December 29, 2014 7:26 AM ET

Diversified Consumer Services

Company Overview of University of Minnesota

Company Overview

University of Minnesota is an educational institution that provides undergraduate and graduate programs. It offers courses in business administration, agriculture and life sciences, arts, medicine, engineering, mathematics, nursing and health sciences, and social services. University of Minnesota was founded in 1851 and is based in Minneapolis, Minnesota.

Minneapolis, MN 55455

United States

Founded in 1851

Phone:

612-625-5000

Key Executives for University of Minnesota

President and Board of Regents
Age: 57
Vice President of Research
Age: 63
Vice President of Health Sciences and Dean of Medical School
Chief of Staff
Vice President for University Relations
Age: 58
Compensation as of Fiscal Year 2014.

University of Minnesota Key Developments

RedHill Biopharma Ltd. Acquires Rights of Patented Technology from University of Minnesota as Part of Ongoing RHB-104 Phase III Crohn's Program

RedHill Biopharma Ltd. announced that it has entered into a license agreement with the University of Minnesota to acquire the rights to a patented technology to support the development of a commercial diagnostic test for detection of Mycobacterium avium subspecies paratuberculosis (‘MAP’) bacterium. The company’s Crohn's disease program RHB-104, currently undergoing a first Phase III study in the U.S., Canada and Israel, is based on increasing evidence supporting the hypothesis that Crohn's disease is caused by MAP infection in susceptible patients. There is currently no validated, commercially available method of detecting the presence or absence of MAP in patients suffering from Crohn's disease and other diseases. As part of its development efforts for RHB-104, RedHill is developing, in collaboration with Quest Diagnostics, a diagnostic test to aid in detecting the presence of MAP in whole blood. The patents acquired from the University of Minnesota are intended to support the ongoing development and validation of this diagnostic test in current and future clinical studies. The company will pay the University of Minnesota a one-time upfront payment and an additional potential milestone payment for the licensed technology. A pre-submission meeting with the FDA to discuss the development path for the diagnostic test is scheduled for January 2015. Currently in a first Phase III study for the treatment of Crohn's disease (the MAP US study), RHB-104 is a proprietary and potentially groundbreaking antibiotic combination therapy in oral capsule formulation, with potent intracellular, antimycobacterial and anti-inflammatory properties. RHB-104 is based on increasing evidence supporting the hypothesis that Crohn's disease is caused by the Mycobacterium avium subspecies paratuberculosis (MAP) infection in susceptible patients. The RHB-104 formulation was originally developed by Professor Thomas Borody, a leading innovator of therapeutic approaches to treating gastrointestinal tract diseases, who also developed the original triple therapy for peptic ulcer disease associated with H. pylori. Several clinical trials were conducted with earlier formulations of RHB-104, including an Australian Phase III study conducted by Pfizer. The company has conducted several supportive studies with the current formulation of RHB-104 and a long-term population pharmacokinetic (Pop-PK) study is ongoing as part of the Phase III MAP US study. The formulation of RHB-104 is covered by several issued and pending patents.

University of Minnesota Presents at The Michigan Growth Capital Symposium, Jun-18-2014 11:30 AM

University of Minnesota Presents at The Michigan Growth Capital Symposium, Jun-18-2014 11:30 AM. Venue: Marriott Resort at Eagle Crest, 1275 S. Huron Street, Ypsilanti, MI 48197, United States. Speakers: Russ Straate, Associate Director, Venture Center.

University of Minnesota Presents at 13th Annual MedTech Investing Conference, May-21-2014 03:30 PM

University of Minnesota Presents at 13th Annual MedTech Investing Conference, May-21-2014 03:30 PM. Venue: Graves Hotel, 601 First Avenue North, Minneapolis, MN 55401, United States. Speakers: Russ Straate, Associate Director, Venture Center.

Similar Private Companies By Industry

Company Name Region
Emergency Training Services, Inc. United States
PIU Management, LLC United States
Wash Cycle Laundry Inc. United States
Childtime Childcare, Inc. United States
Rent The Runway, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact University of Minnesota, please visit www1.umn.edu. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.